Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Gomez

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2009
Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell linesMariano R Gabri, Laura L Otero, Daniel E Gomez, et al.
Anticancer Research|July 28, 2004
Role of protein kinase C-dependent signaling pathways in the antiangiogenic properties of nafoxidineMariana S De Lorenzo, Hernan G Farina, Daniel F Alonso, et al.
Journal of Surgical Oncology|September 5, 2002
Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulationSantiago Giron, Agueda M Tejera, Giselle V Ripoll, et al.
Anticancer Research|December 29, 2010
Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancerGiselle V Ripoll, Juan Garona, Guillermo A Hermo, et al.
In Vivo (Athens, Greece)|January 6, 2007
Desmopressin reduces melanoma lung metastasis in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1Giselle V Ripoll, Hernán G Farina, Hitoshi Yoshiji, et al.
Clinical Genetics|March 2, 2019
Telomeropathies: Etiology, diagnosis, treatment and follow-up. Ethical and legal considerationsRomina G Armando, Diego L Mengual Gomez, Julián Maggio, et al.
Frontiers in Oncology|November 20, 2012
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancerValeria I Segatori, Ana M Vazquez, Daniel E Gomez, et al.
Clinical & Experimental Metastasis|May 6, 2016
Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour modelsJuan Garona, Marina Pifano, Maria B Pastrian, et al.
Anticancer Research|September 10, 2014
Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c miceJuan Garona, Marina Pifano, Alejandra M Scursoni, et al.
Breast Cancer Research and Treatment|October 15, 2013
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer modelGiselle V Ripoll, Juan Garona, Marina Pifano, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2009
Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell linesMariano R Gabri, Laura L Otero, Daniel E Gomez, et al.
Anticancer Research|July 28, 2004
Role of protein kinase C-dependent signaling pathways in the antiangiogenic properties of nafoxidineMariana S De Lorenzo, Hernan G Farina, Daniel F Alonso, et al.
Journal of Surgical Oncology|September 5, 2002
Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulationSantiago Giron, Agueda M Tejera, Giselle V Ripoll, et al.
Anticancer Research|December 29, 2010
Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancerGiselle V Ripoll, Juan Garona, Guillermo A Hermo, et al.
In Vivo (Athens, Greece)|January 6, 2007
Desmopressin reduces melanoma lung metastasis in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1Giselle V Ripoll, Hernán G Farina, Hitoshi Yoshiji, et al.
Clinical Genetics|March 2, 2019
Telomeropathies: Etiology, diagnosis, treatment and follow-up. Ethical and legal considerationsRomina G Armando, Diego L Mengual Gomez, Julián Maggio, et al.
Frontiers in Oncology|November 20, 2012
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancerValeria I Segatori, Ana M Vazquez, Daniel E Gomez, et al.
Clinical & Experimental Metastasis|May 6, 2016
Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour modelsJuan Garona, Marina Pifano, Maria B Pastrian, et al.
Anticancer Research|September 10, 2014
Insight into the effect of the vasopressin analog desmopressin on lung colonization by mammary carcinoma cells in BALB/c miceJuan Garona, Marina Pifano, Alejandra M Scursoni, et al.
Breast Cancer Research and Treatment|October 15, 2013
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer modelGiselle V Ripoll, Juan Garona, Marina Pifano, et al.
Pageof 5